This week, Beyond Biotech examined a critical challenge facing cell therapy developers: the hidden costs of manufacturing inconsistency. The episode explored how variability introduced during cryopreservation can cascade through supply chains, ultimately compromising product quality and clinical outcomes. By addressing freeze protocols early in development rather than troubleshooting downstream, companies can build more resilient and scalable manufacturing processes.
Episodes This Week
Get a free sample digest — no signup needed
Real AI summaries from top beyond biotech podcasts, straight to your inbox.
or
No spam, unsubscribe anytime. We'll send one sample digest, then you decide.
Other Weeks
This Week in Beyond Biotech (May 4 - May 10, 2026)
1 episode · May 4 – May 10
This Week in Beyond Biotech (Apr 27 - May 3, 2026)
1 episode · Apr 27 – May 3
This Week in Beyond Biotech (Apr 20 - Apr 26, 2026)
1 episode · Apr 20 – Apr 26
This Week in Beyond Biotech (Apr 13 - Apr 19, 2026)
1 episode · Apr 13 – Apr 19
This Week in Beyond Biotech (Apr 6 - Apr 12, 2026)
1 episode · Apr 6 – Apr 12
This Week in Beyond Biotech (Mar 30 - Apr 5, 2026)
1 episode · Mar 30 – Apr 5
This Week in Beyond Biotech (Mar 23 - Mar 29, 2026)
1 episode · Mar 23 – Mar 29